{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-006594","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.193841+00:00","generated_at":"2026-06-02T23:16:20.010313+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Kumar Budur promoted to EVP and Chief Medical & Scientific Officer at Harmony Biosciences","bullets":["Appointed EVP & Chief Medical & Scientific Officer effective May 1, 2024.","Annual salary raised from $500,000 to $575,000; target bonus remains 50% of salary.","Receives 75,000 RSUs and 75,000 stock options vesting over four years.","Dr. Budur had been Chief Medical Officer; biography previously disclosed in proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-006594","json":"https://secwatch.observer/filing/0001558370-24-006594.json","markdown":"https://secwatch.observer/filing/0001558370-24-006594.md","text":"https://secwatch.observer/filing/0001558370-24-006594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/0001558370-24-006594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/hrmy-20240501x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:16:20.010313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c9c3476851","claim":"Kumar Budur was appointed as Executive Vice President and Chief Medical & Scientific Officer at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"appointed Kumar Budur, M.D., M.S., the Company’s Chief Medical Officer, to the title of Executive Vice President and Chief Medical & Scientific Officer (the “Appointment”), effective on May 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/0001558370-24-006594-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Medical & Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}